Literature DB >> 32347053

[Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future].

Zi-Wei Ye1, Dong-Yan Jin1.   

Abstract

The ongoing outbreak of the coronavirus disease 2019 (COVID-19) as named by the World Health Organization has millions of confirmed cases around the world and has claimed hundreds of thousands of lives. The virus was named SARS-CoV-2 in February by International Committee on Taxonomy of Viruses. COVID-19 presents as fever, dry cough, dyspnea, headache and pneumonia. In a small subset of severe cases, the disease quickly progresses to respiratory failure and even death. Since the 21st century, there have been three major outbreaks caused by human coronaviruses, including the severe acute respiratory syndrome (SARS) that broke out in 2003, the Middle East respiratory syndrome (MERS) in 2012, and the recent pandemic of COVID-19. Since 2003, significant progress has been made in the study of SARS-CoV and MERS-CoV concerning their natural origins, pathogenesis, antiviral development and vaccine design. Since SARS-CoV-2 and SARS-CoV are closely related, previous findings on SARS-CoV are highly relevant to a better understanding as well as diagnosis, treatment, prevention and control of SARS-CoV-2. In this review, we highlight recent progresses in the field; compare the biological characteristics of SARS-CoV and SARS-CoV-2; summarize the urgently-needed diagnostic, treatment, prevention and control options; and provide future perspectives for the outcome of the outbreak and research questions to be answered, including some of the difficulties in vaccine development. Hopefully, our comments and suggestions would prove useful for the control of the SARS-CoV-2 epidemic in China and the world.

Entities:  

Keywords:  Middle East respiratory syndrome coronavirus; SARS-CoV-2; antiviral therapy; coronavirus disease 2019 (COVID-19); coronavirus vaccines; severe acute respiratory syndrome coronavirus (SARS-CoV); virological diagnosis

Mesh:

Substances:

Year:  2020        PMID: 32347053     DOI: 10.13345/j.cjb.200115

Source DB:  PubMed          Journal:  Sheng Wu Gong Cheng Xue Bao        ISSN: 1000-3061


  4 in total

Review 1.  The next-generation coronavirus diagnostic techniques with particular emphasis on the SARS-CoV-2.

Authors:  Maged G Hemida
Journal:  J Med Virol       Date:  2021-03-26       Impact factor: 2.327

2.  Effect of COVID-19 pandemic on anxiety depression and intention to go to hospital in chronic patients.

Authors:  Yasemin Kaya; Sedat Bostan; Ahmet Kaya; Ömer Karaman; Ahmet Karataş; Seçkin Dereli
Journal:  Int J Clin Pract       Date:  2021-04-27       Impact factor: 3.149

3.  Two-month follow-up of persons with SARS-CoV-2 infection-Zambia, September 2020: a cohort study.

Authors:  James Exnobert Zulu; Dabwitso Banda; Jonas Zajac Hines; Musisye Luchembe; Suilanje Sivile; Mpanji Siwingwa; Davies Kampamba; Khozya Davie Zyambo; Robert Chirwa; Lameck Chirwa; Warren Malambo; Danielle Barradas; Nyambe Sinyange; Simon Agolory; Lloyd Berdad Mulenga; Sombo Fwoloshi
Journal:  Pan Afr Med J       Date:  2022-01-11

4.  Perspectives on the Early Quality of Evidence Guiding the Therapeutic Management of SARS-CoV-2: A Systematic Literature Review.

Authors:  Kaushik Subramanian; Anuradha Nalli; Vinitha Senthil; Saurabh Jain; Aravind Nayak; Amit Bhat
Journal:  Adv Ther       Date:  2020-08-18       Impact factor: 4.070

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.